SUBSCRIBERS
Hyphens Pharma jumps 50% after successful UK patent
Published Tue, Jul 14, 2020 · 09:50 PM
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
SHARES of Catalist-listed Hyphens Pharma International made gains amid active trading on Tuesday, following an announcement that its patent for Ceradan Advanced has been granted in the UK.
Shares of the pharmaceutical and consumer healthcare group surged by 50 per cent, or 16 Singapore cents, to finish at S$0.48 on Tuesday.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.